Home / World / World Lifestyle / Archive by category Health & Medical (Page 15)

Archive by category Health & Medical

Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma

SHANGHAI, July 17, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: [...]

Invixium Acquires Triax Technologies to Expand its Biometric Solutions with AI-based RTLS Offering for Improved Safety and Productivity at Industrial Sites and Critical Infrastructure

TORONTO, July 17, 2024 (Korea Bizwire) – Invixium, a global leader in biometric access control, workforce, and visitor management solutions, proudly announces its acquisition of US-based Triax Technologies (Triax). This strategic acquisition expands Invixium’s portfolio with Triax’s AI-based RTLS (Real-Time Location Systems) and connected worker solutions, designed to improve worker productivity and equipment utilization. With this move, [...]

Bon Secours Mercy Health and Philips Sign Multi-year Strategic Collaboration

July 17, 2024 Patient monitoring platform to deliver tools and time to help patients across 40+ care sites Amsterdam, the Netherlands, and Cincinnati, Ohio – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation’s largest Catholic health systems, today announced a multi-year strategic collaboration for patient [...]

Io Therapeutics, Inc., Presented Today Results from Studies of IRX4204, the Company’s Phase II Clinical Development Stage, Highly Selective RXR Nuclear Receptor Agonist Compound, Supporting Its Potential Use for Treatment of Amyotrophic Lateral Sclerosis (ALS)

SPRING, Texas, July 16, 2024 (Korea Bizwire) – Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis (ALS). The presentation titled “The RXR Nuclear Receptor Agonist Compound IRX4204 is a [...]

NetSfere Integrates Microsoft Nuance’s Dragon Medical Speech Recognition Into Its Secure Messaging Platform, Empowering Healthcare Professionals With Unmatched Compliance and Security

NetSfere Introduces Hands-Free Speech-to-Text Feature Enabling Efficient and Secure Communication of Medical Jargon for Healthcare Professionals CHICAGO, July 16, 2024 (Korea Bizwire) – NetSfere, a global provider of next-generation secure and compliant messaging and mobility solutions, today reaffirms its collaboration with Microsoft and Nuance technology to equip healthcare organizations and professionals with encrypted and compliant communications [...]

Best-in-class Just Got Better; Smith+Nephew Announces 510(k) Clearance of New CATALYSTEM™ Primary Hip System

Engineered for precision, confidence and efficiency in surgery – and compatible with the CORI◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug Administration. The system is designed to address the evolving demands of [...]

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

WASHINGTON, July 15, 2024 (Korea Bizwire) – Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-dose vaccine at Makerere University Walter Reed Project (MUWRP) in Uganda. There are currently no approved vaccines for this strain of ebolavirus, which saw an outbreak end just last year. [...]

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Mont-Saint-Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Scott Holstine as Chief Commercial Officer. In this role, Scott will [...]

New Report Highlights Global Trends and Advances in Chronic Lymphocytic Leukemia Research and Treatment

BOSTON, Jul. 11 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a significant research report entitled Chronic Lymphocytic Leukemia (CLL) – Global Clinical Trial Landscape. This expert monthly report, provided by the [...]

Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024

VANCOUVER, British Columbia, July 11, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will report its second quarter 2024 financial results after market close on August 1, 2024. Following the [...]